Compare GSK plc (GSK) vs PPG Industries, Inc. (PPG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs PPG Industries, Inc. — how do they compare? GSK plc trades at $52.85 (market cap $101.34B), while PPG Industries, Inc. trades at $115.36 (market cap $25.70B). The key difference: GSK plc is far larger — about 3.9× PPG Industries, Inc.'s market cap, and GSK plc pays the higher dividend (3.49%). Which is the better fit depends on your goals.
| GSK | PPG | |
|---|---|---|
Market Cap | $101.34B | $25.70B |
Sector | Health | Basic Materials |
52-Week High | $61.18 | $131.56 |
52-Week Low | $36.20 | $94.34 |
Enterprise Value | $121.95B | $31.81B |
Dividend Yield | 3.49% | 2.46% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $52.64, up 2.7% on the day, with a bearish technical signal despite recent earnings beats. The company reported Q1 2026 EPS of $1.24, beating estimates of $1.16, and maintains strong profitability with a 17.78% net income margin. Positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline strength, while a pending acquisition of Nuvalent, Inc. signals strategic expansion.
GSK offers value with a P/E of 13.71 and stable cash flows, but faces risks from clinical setbacks, as seen in the terminated Alector partnership. Analyst sentiment is mixed with 31% buy ratings, reflecting cautious optimism amid competitive and regulatory pressures. The stock's outlook hinges on execution of growth initiatives and pipeline developments.
PPG Industries trades at $117.77, up 2.7% today, with a bullish technical signal and strong fundamentals including a 9.83% net margin and 21.09% ROE. Recent earnings beat expectations in Q1 2026, and analyst consensus is a Buy with a $131.75 price target. The company maintains innovation momentum with new product launches in aerospace and marine coatings, supporting long-term growth prospects.
The outlook for PPG is positive, driven by earnings growth and strategic innovations, but risks include economic sensitivity and competitive pressures. Valuation metrics like a P/E of 16.52 suggest reasonable pricing, with upside potential if the company meets Q2 2026 EPS expectations of $2.25.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About PPG Industries, Inc.
PPG is a global producer of coatings. The company is the world's largest producer of coatings after the purchase of selected Akzo Nobel assets. PPG's products are sold to a wide variety of end users, including the automotive, aerospace, construction, and industrial markets. The company has a footprint in many regions around the globe, with less than half of sales coming from North America in recent years. PPG is focused on its coatings and specialty products and expansion into emerging regions, as exemplified by the Comex acquisition.
Read more on PPG →
